AXSM
Price
$177.03
Change
+$2.70 (+1.55%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
8.79B
47 days until earnings call
Intraday BUY SELL Signals
JBPHF
Price
$0.83
Change
-$0.12 (-12.63%)
Updated
Jan 6 closing price
Capitalization
794.09M
Intraday BUY SELL Signals
Interact to see
Advertisement

AXSM vs JBPHF

Header iconAXSM vs JBPHF Comparison
Open Charts AXSM vs JBPHFBanner chart's image
Axsome Therapeutics
Price$177.03
Change+$2.70 (+1.55%)
Volume$6.8K
Capitalization8.79B
Jacobio Pharmaceuticals Group
Price$0.83
Change-$0.12 (-12.63%)
Volume$570
Capitalization794.09M
AXSM vs JBPHF Comparison Chart in %
View a ticker or compare two or three
VS
AXSM vs. JBPHF commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXSM is a Hold and JBPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (AXSM: $174.33 vs. JBPHF: $0.83)
Brand notoriety: AXSM and JBPHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXSM: 94% vs. JBPHF: 32%
Market capitalization -- AXSM: $8.79B vs. JBPHF: $794.09M
AXSM [@Biotechnology] is valued at $8.79B. JBPHF’s [@Biotechnology] market capitalization is $794.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $115.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXSM’s FA Score shows that 0 FA rating(s) are green whileJBPHF’s FA Score has 0 green FA rating(s).

  • AXSM’s FA Score: 0 green, 5 red.
  • JBPHF’s FA Score: 0 green, 5 red.
According to our system of comparison, both AXSM and JBPHF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXSM’s TA Score shows that 4 TA indicator(s) are bullish.

  • AXSM’s TA Score: 4 bullish, 4 bearish.

Price Growth

AXSM (@Biotechnology) experienced а +1.43% price change this week, while JBPHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

AXSM is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXSM($8.79B) has a higher market cap than JBPHF($794M). AXSM YTD gains are higher at: -4.550 vs. JBPHF (-12.269).
AXSMJBPHFAXSM / JBPHF
Capitalization8.79B794M1,107%
EBITDA-213.94MN/A-
Gain YTD-4.550-12.26937%
P/E RatioN/AN/A-
Revenue561MN/A-
Total Cash325MN/A-
Total Debt219MN/A-
FUNDAMENTALS RATINGS
AXSM: Fundamental Ratings
AXSM
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
34
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXSMJBPHF
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
71%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
13%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AXSM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BINCX25.420.06
+0.24%
Brandes International Small Cap Equity C
VITSX166.71-0.30
-0.18%
Vanguard Total Stock Market Idx I
MNDFX8.92-0.02
-0.22%
Manning & Napier Disciplined Value I
VSOIX47.56-0.12
-0.25%
Victory Sycamore Small Company Opp I
NTKLX76.79-0.56
-0.72%
Voya Multi-Manager International Sm Cp A

AXSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with XENE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXSM
1D Price
Change %
AXSM100%
-1.41%
XENE - AXSM
37%
Loosely correlated
-2.11%
VANI - AXSM
36%
Loosely correlated
N/A
PLRX - AXSM
35%
Loosely correlated
-3.01%
SYRE - AXSM
35%
Loosely correlated
-3.87%
VNDA - AXSM
33%
Loosely correlated
+0.40%
More

JBPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBPHF has been closely correlated with RAPT. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBPHF jumps, then RAPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBPHF
1D Price
Change %
JBPHF100%
N/A
RAPT - JBPHF
79%
Closely correlated
-0.99%
AXSM - JBPHF
32%
Poorly correlated
-1.41%
PYPD - JBPHF
23%
Poorly correlated
-5.16%
LXRX - JBPHF
21%
Poorly correlated
+1.69%
TNYA - JBPHF
20%
Poorly correlated
+2.96%
More